Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.56 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL8011246 | 1.00 | ALDH1A1 (0.56) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL2482818 | 1.00 | ALDH1A1 (0.56) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL28838063 | 0.98 | ALDH1A1 (0.54) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL17260502 | 0.94 | ALDH1A1 (0.50) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Triphosphate SCHEMBL22659158 | 0.92 | ALDH1A1 (0.52) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Imidazole SCHEMBL29042475 | 0.90 | ALDH1A1 (0.50) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL28404443 | 0.86 | ALDH1A1 (0.42) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL1352614 | 0.86 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL1090914 | 0.86 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL22659156 | 0.86 | ALDH1A1 (0.68) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105026414-B | P1,P4Two（Uridine 5 '）The manufacture method of four phosphates | YAMASA 酱油株式会社 | 2017-06-23 | — | — | CN | claimed |
| US-11208428-B2 | Method for producing P1,P4-di(uridine 5′-) tetraphosphate | YAMASA CORPORATION (JP) | 2021-12-28 | — | — | US | disclosed |
| CN-110590887-B | Preparation method of phosphate | 江苏金殳医药科技有限公司 | 2020-12-15 | — | — | CN | disclosed |
| CN-106928269-B | Preparation method of phosphate | 长春普华制药股份有限公司 | 2020-03-24 | — | — | CN | disclosed |
| CN-110590887-A | Preparation method of phosphate | 南京帝昌医药科技有限公司 | 2019-12-20 | — | — | CN | disclosed |
| US-20190092803-A1 | METHOD FOR PRODUCING P1,P4-DI(URIDINE 5'-) TETRAPHOSPHATE | YAMASA CORPORATION (JP) | 2019-03-28 | — | — | US | disclosed |
| US-10179799-B2 | Method for producing P1,P4-di(uridine 5′-) tetraphosphate | YAMASA CORPORATION (JP) | 2019-01-15 | — | — | US | disclosed |
| CN-106928269-A | A kind of preparation method of phosphate | 长春普华制药股份有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-105026414-B | P1,P4Two（Uridine 5 '）The manufacture method of four phosphates | YAMASA 酱油株式会社 | 2017-06-23 | — | — | CN | disclosed |
| EP-2940030-B1 | METHOD FOR PRODUCING P1,P4-DI(URIDINE 5'-)TETRAPHOSPHATE | YAMASA CORP (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-20160194347-A1 | METHOD FOR PRODUCING P1,P4-DI(URIDINE 5'-) TETRAPHOSPHATE | YAMASA CORPORATION (JP) | 2016-07-07 | — | — | US | disclosed |
| EP-2940030-A1 | METHOD FOR PRODUCING P1,P4-DI(URIDINE 5'-)TETRAPHOSPHATE | YAMASA CORPORATION (JP) | 2015-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092803-A1 | METHOD FOR PRODUCING P1,P4-DI(URIDINE 5'-) TETRAPHOSPHATE | UPP1, UMPS, UGP2 | ALDH1A1 1776/4885FKBP5 3085/4885FDPS 156/4885 |
| US-11208428-B2 | Method for producing P1,P4-di(uridine 5′-) tetraphosphate | UPP1, UMPS, UGP2 | ALDH1A1 1779/4885FKBP5 3103/4885FDPS 155/4885 |
| US-20160194347-A1 | METHOD FOR PRODUCING P1,P4-DI(URIDINE 5'-) TETRAPHOSPHATE | UPP1, UMPS, UGP2 | ALDH1A1 1776/4885FKBP5 3085/4885FDPS 156/4885 |
| US-10179799-B2 | Method for producing P1,P4-di(uridine 5′-) tetraphosphate | UPP1, UMPS, UGP2 | ALDH1A1 1779/4885FKBP5 3103/4885FDPS 155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.